| Søg service: |
|
Populære byer København K Århus C Roskilde Frederiksberg Odense C Horsens Brøndby Glostrup Aalborg Valby Odder Randers Svendborg Vejle Rødovre Kolding Silkeborg Sønderborg Fredericia Haderslev |
Annoncer:
3500 Værløse Lejrvej 39-41, St, Kr Værløse
Egalet A/S kort
Egalet A/S
Telefon: 44 47 80 80
Websted (egalet.dk)
E-mail-adresse: [javascript protected email address]
Annoncer
SYGEPLEJEARTIKLER, EN GROS
Tjenesteydelseskategorier
SYGEPLEJEARTIKLER EN GROSRelaterede Services
AnnoncerINNOVATORS IN PAIN MANAGEMENT
Egalet Ltd. is a specialty pharma company focusing on pain management. Based on the Egalet technology, the company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world's first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.
Egalet Ltd. is a specialty pharmaceutical company using its patented technology to produce novel therapeutics on its own and with partners. Based on the proprietary technology, Egalet is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. In addition, Egalet has collaborations with pharmaceutical and biotechnology companies in the initial phase of clinical testing.
Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet. In addition, the Egalet technology, a novel, patented drug delivery platform, was designed to prevent easy extraction and to deter the abuse of medications via known routes of abuse, including chewing, snorting, and injecting. The uniquely shaped, patient-friendly tablet consists of matrix and can add a shell or coat. By altering the composition of the shell and matrix, a variety of extended-release formulations can be produced. The technology offers a predictable and tailored pharmacokinetic profile, lacks a significant food effect and alcohol dose dumping, and can be used with a broad range of opioids and non-opioids. Egalet has extensively filed patents to protect its inventions covering both the technology and product-specific patents.
Annoncer